Do you routinely administer desmopressin to patients with intracerebral hemorrhage who are also on anti-platelet therapy?  

At our institution, we always administer desmopressin (0.4 micrograms/kg) for patients on anti-platelet therapy with intracranial hemorrhage, regardless of the etiology. There is no high-level data to guide this practice. We performed a retrospective review of patients admitted to the University of ...

We also always administer the higher dose (0.4 mcg/kg) for patients with ICH on antiplatelet agents. This being said, this is institutional practice, and the data is somewhat limited. I think, given it is seen as safe with limited downside, it is commonly used, as opposed to platelet transfusion, fo...